EVIO Inc (EVIO)

[fiveteenthirty]

Its like we get the regular "news bump" of volume and then once the diluters jump in. price drops. And because there has been no effective awareness campaign in place (2 years and running) there is no deluge of "new" investors who have bookmarked and are following the story etc. Rather its just dumping of paper as the price drops. Likely more regulars just picking up cheap paper. Leaving the holders thinking awesome. cheap paper!

But definitely not an environment the greater "market" wants to play in. That this stock isnt trading in a range of 2-3$ right now is criminal.

The fact that they chose their lead in tagline on their twitter/site to be: Passion Science Innovation - points to the crazy bad decisions in messaging.

Passion is fine, i guess, sure, internally communicated maybe? but you are an ANALYTICAL SCIENTIFIC TESTING COMPANY- CHEMISTS, SCIENTISTS perform critical laboratory tests to ensure the health and safety of a nation. And you want people to believe its your passion they should trust/rely on versus say SCIENCE!

First thing i look for in a doctor: forget their degree or specialties: do they have a passion for doctoring that surpasses every other doctor? The last five patients died on the operating table.... but you cant deny his/her passion passion for doctoring. Drilling down even further. What is EVIOs passion all about? Cannabis? Cannabis Testing? Life? Depressed share prices? Low Volume? Bad Messaging? Share Dilution? Who know? My guess is they couldnt even answer the question- it just feels good. Like a bunny that youre scratching behind the ears... it takes a few hops in the dreamland of your echo chamber... out into the real world whereupon an eagle swoops in and carries off the screaming bunny for dinner.

And book value has nothing to do with it. This is a small cap deal that has a potentially massive global upside. People will pay for that. Because no awareness campaigns are/ have been running to inform and hilight these critical points on a daily basis to the greater marketplace- doldrums are the result.

Again- forget book value. This isnt a fully matured blue chip billion dollar revenue deal with 100 quarters of performance. This is a small cap deal who have essentially cornered the marketplace of a mission critical specialty in the fastest growing agricultural sector on Earth.
The stock is worth whatever people will pay for it.